Verastem takes a shot at tough public market, files for $50M IPO
04 November 2011
Nancy Faigen
Please Login to read the full article.
04 November 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Verastem ($45m) and Cempra ($66m) outline IPO ranges and strategies
- The return of the preclinical IPO? Cancer stem cell firm Verastem raises $55M
- Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
- Cancer developer Merrimack dives into a tough IPO pool with a $172M filing
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
